Skip to main navigation
Skip to search
Skip to main content
OSU Center for Health Sciences Research Profiles Home
Help & Contact
Press / Media
Search by expertise, name or affiliation
When is crossover desirable in cancer drug trials and when is it problematic?
, V. Prasad
Contribution to journal
Dive into the research topics of 'When is crossover desirable in cancer drug trials and when is it problematic?'. Together they form a unique fingerprint.